{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:58:05Z","timestamp":1791421085780,"version":"4.3.3"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.soc.2006.05.007","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T10:10:36Z","timestamp":1168423836000},"page":"625-638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Role of Radioactive Iodine in the Treatment of Well-differentiated Thyroid Cancer"],"prefix":"10.1016","volume":"15","author":[{"given":"Ronald J.","family":"Weigel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. Ross","family":"McDougall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.soc.2006.05.007_bib1","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1001\/jama.1946.02870490016004","article-title":"Radioactive iodine therapy: Effect on functioning metastases of adenocarcinoma of the thyroid","volume":"132","author":"Seidlin","year":"1946","journal-title":"JAMA"},{"key":"10.1016\/j.soc.2006.05.007_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mce.2003.10.059","article-title":"Advances in Na(+)\/I(-) symporter (NIS) research in the thyroid and beyond","volume":"213","author":"Dohan","year":"2003","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.soc.2006.05.007_bib3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/379458a0","article-title":"Cloning and characterization of the thyroid iodide transporter","volume":"379","author":"Dai","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.soc.2006.05.007_bib4","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1210\/jcem.87.7.8679","article-title":"Pendrin is an iodide-specific apical porter responsible for iodide efflux from thyroid cells","volume":"87","author":"Yoshida","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2006.05.007_bib5","first-page":"2493","article-title":"Iodide symporter gene expression in human thyroid tumors","volume":"83","author":"Arturi","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2006.05.007_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/thy.1999.9.405","article-title":"Development of reverse transcription-competitive polymerase chain reaction method to quantitate the expression levels of human sodium iodide symporter","volume":"9","author":"Ryu","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.soc.2006.05.007_bib7","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI1259","article-title":"Increased expression of the sodium\/iodide symporter in papillary thyroid carcinomas","volume":"101","author":"Saito","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.soc.2006.05.007_bib8","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1210\/jc.2002-021544","article-title":"Immunohistochemical profile of the sodium\/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections","volume":"88","author":"Wapnir","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2006.05.007_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/10507250150500649","article-title":"Absence of sodium\/iodide symporter gene mutations in differentiated human thyroid carcinomas","volume":"11","author":"Russo","year":"2001","journal-title":"Thyroid"},{"key":"10.1016\/j.soc.2006.05.007_bib10","first-page":"2697","article-title":"Rapid communication: predominant intracellular overexpression of the Na(+)\/I(-) symporter (NIS) in a large sampling of thyroid cancer cases","volume":"86","author":"Dohan","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2006.05.007_bib11","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1006\/bbrc.1997.7715","article-title":"Retinoic acid increases sodium\/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells","volume":"240","author":"Schmutzler","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.soc.2006.05.007_bib12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1089\/105072504323150732","article-title":"Gene therapy for thyroid cancer: current status and future prospects","volume":"14","author":"Spitzweg","year":"2004","journal-title":"Thyroid"},{"key":"10.1016\/j.soc.2006.05.007_bib13","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1089\/thy.2004.14.889","article-title":"In vitro and in vivo properties of a human anaplastic thyroid carcinoma cell line transfected with the sodium iodide symporter gene","volume":"14","author":"Lee","year":"2004","journal-title":"Thyroid"},{"key":"10.1016\/j.soc.2006.05.007_bib14","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1210\/endo.138.10.5571","article-title":"Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+\/I- symporter gene","volume":"138","author":"Shimura","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.soc.2006.05.007_bib15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ymthe.2005.05.013","article-title":"A preclinical large animal model of adenovirus-mediated expression of the sodium-iodide symporter for radioiodide imaging and therapy of locally recurrent prostate cancer","volume":"12","author":"Dwyer","year":"2005","journal-title":"Mol Ther"},{"key":"10.1016\/j.soc.2006.05.007_bib16","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-2265.2005.02358.x","article-title":"Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years","volume":"63","author":"Brierley","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.soc.2006.05.007_bib17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00268-002-6612-1","article-title":"Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940\u20131999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients","volume":"26","author":"Hay","year":"2002","journal-title":"World J Surg"},{"key":"10.1016\/j.soc.2006.05.007_bib18","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1210\/jc.2003-031167","article-title":"Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer","volume":"89","author":"Sawka","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2006.05.007_bib19","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1210\/jcem.82.11.4373","article-title":"Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients","volume":"82","author":"Loh","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2006.05.007_bib20","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1210\/jcem.86.4.7407","article-title":"Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer","volume":"86","author":"Mazzaferri","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2006.05.007_bib21","first-page":"714","article-title":"The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients","volume":"75","author":"Samaan","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2006.05.007_bib22","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0360-3016(01)02686-4","article-title":"Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy","volume":"52","author":"Chow","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.soc.2006.05.007_bib23","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/cncr.10683","article-title":"Follicular thyroid carcinoma: prognostic factors and the role of radioiodine","volume":"95","author":"Chow","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2006.05.007_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/(SICI)1097-0142(19980115)82:2<389::AID-CNCR19>3.0.CO;2-V","article-title":"The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma","volume":"82","author":"Tsang","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2006.05.007_bib25","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1530\/eje.1.02014","article-title":"Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report","volume":"153","author":"Pacini","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.soc.2006.05.007_bib26","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.surg.2004.06.058","article-title":"Large remnant 131I ablation as an alternative to completion\/total thyroidectomy in the treatment of well-differentiated thyroid cancer","volume":"136","author":"Leblanc","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/j.soc.2006.05.007_bib27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00006231-199603000-00005","article-title":"What is the role of 1100 MBq (<30 mCi) radioiodine 131I in the treatment of patients with differentiated thyroid cancer?","volume":"17","author":"van Wyngaarden","year":"1996","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.soc.2006.05.007_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/jcem.85.1.6310","article-title":"Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?","volume":"85","author":"Cailleux","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2006.05.007_bib29","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1515\/CCLM.2005.142","article-title":"Thyroglobulin assay 4 weeks after thyroidectomy predicts outcome in low-risk papillary thyroid carcinoma","volume":"43","author":"Giovanella","year":"2005","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.soc.2006.05.007_bib30","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1210\/jc.2002-021925","article-title":"Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma","volume":"88","author":"Pacini","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2006.05.007_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00006231-200402000-00006","article-title":"Clinical implications of the differences between diagnostic 123I and post-therapy 131I scans","volume":"25","author":"Cohen","year":"2004","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.soc.2006.05.007_bib32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00003072-200101000-00002","article-title":"Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer","volume":"26","author":"Mandel","year":"2001","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.soc.2006.05.007_bib33","first-page":"77","article-title":"123I: almost a designer radioiodine for thyroid scanning","volume":"43","author":"Park","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1016\/j.soc.2006.05.007_bib34","first-page":"1164","article-title":"Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?","volume":"46","author":"Ma","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.soc.2006.05.007_bib35","first-page":"92","article-title":"Comparison of the distribution of diagnostic and thyroablative I-131 in the evaluation of differentiated thyroid cancers","volume":"20","author":"Nemec","year":"1979","journal-title":"J Nucl Med"},{"key":"10.1016\/j.soc.2006.05.007_bib36","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/00003072-198511000-00009","article-title":"Evaluation of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients","volume":"10","author":"Ramanna","year":"1985","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.soc.2006.05.007_bib37","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1089\/thy.2000.10.573","article-title":"Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer?","volume":"10","author":"Fatourechi","year":"2000","journal-title":"Thyroid"},{"key":"10.1016\/j.soc.2006.05.007_bib38","article-title":"74 MBq radioiodine 131I does not prevent uptake of therapeutic doses of 131I (i.e. it does not cause stunning) in differentiated thyroid cancer","volume":"18","author":"McDougall","year":"1997","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.soc.2006.05.007_bib39","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/01.rlu.0000218539.51019.cb","article-title":"Metastatic struma ovarii: the burden of truth","volume":"3","author":"McDougall","year":"2006","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.soc.2006.05.007_bib40","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00006231-200306000-00015","article-title":"The interpretation of 131I scans in the evaluation of thyroid cancer, with an emphasis on false positive findings","volume":"24","author":"Carlisle","year":"2003","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.soc.2006.05.007_bib41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/105072503321582060","article-title":"Radioactive iodine and the salivary glands","volume":"13","author":"Mandel","year":"2003","journal-title":"Thyroid"},{"key":"10.1016\/j.soc.2006.05.007_bib42","first-page":"1551","article-title":"Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma","volume":"39","author":"Alexander","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1016\/j.soc.2006.05.007_bib43","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1007\/s00259-002-0969-0","article-title":"Long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional study","volume":"29","author":"Zettinig","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.soc.2006.05.007_bib44","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/01.IOP.0000092802.75899.F8","article-title":"Nasolacrimal duct obstruction associated with radioactive iodine therapy for thyroid carcinoma","volume":"19","author":"Shepler","year":"2003","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.soc.2006.05.007_bib45","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2214\/ajr.176.4.1760869","article-title":"Iodine-131 and the pregnant patient","volume":"176","author":"Berlin","year":"2001","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.soc.2006.05.007_bib46","first-page":"606","article-title":"Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients","volume":"37","author":"Schlumberger","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1016\/j.soc.2006.05.007_bib47","first-page":"1418","article-title":"Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine","volume":"35","author":"Pacini","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1016\/j.soc.2006.05.007_bib48","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/bjc.1997.130","article-title":"Leukaemias and cancers following iodine-131 administration for thyroid cancer","volume":"75","author":"de Vathaire","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.soc.2006.05.007_bib49","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/bmj.2.5212.1545","article-title":"Leukaemia following radioiodine treatment of thyrotoxicosis","volume":"5212","author":"Pochin","year":"1960","journal-title":"BMJ"},{"key":"10.1016\/j.soc.2006.05.007_bib50","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1365-2265.1995.tb02932.x","article-title":"Chronic myeloid leukaemia following 131I treatment for thyroid carcinoma: a report of two cases and review of the literature","volume":"43","author":"Shimon","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.soc.2006.05.007_bib51","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/1097-0142(20010715)92:2<225::AID-CNCR1313>3.0.CO;2-B","article-title":"The development of breast carcinoma in women with thyroid carcinoma","volume":"92","author":"Chen","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2006.05.007_bib52","first-page":"337","article-title":"Subsequent malignancies in patients treated with 131-iodine for thyroid cancer","volume":"168","author":"Glanzmann","year":"1992","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.soc.2006.05.007_bib53","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1667\/0033-7587(2002)158[0220:REOBCR]2.0.CO;2","article-title":"Radiation effects on breast cancer risk: a pooled analysis of eight cohorts","volume":"158","author":"Preston","year":"2002","journal-title":"Radiat Res"},{"key":"10.1016\/j.soc.2006.05.007_bib54","first-page":"4991","article-title":"Radiotherapy-induced lung toxicity: risk factors and prevention strategies","volume":"23","author":"Nieder","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1016\/j.soc.2006.05.007_bib55","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1210\/jcem-17-11-1263","article-title":"Radiation pneumonitis and fibrosis: a complication of radioiodine treatment of pulmonary metastases from cancer of the thyroid","volume":"17","author":"Rall","year":"1957","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2006.05.007_bib56","first-page":"521","article-title":"Anaplastic carcinoma following well-differentiated thyroid cancer: etiological considerations","volume":"55","author":"Kapp","year":"1982","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.soc.2006.05.007_bib57","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00003072-198902000-00009","article-title":"The scope of false-positive iodine-131 images for thyroid carcinoma","volume":"14","author":"Greenler","year":"1989","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.soc.2006.05.007_bib58","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00003072-199510000-00002","article-title":"Whole-body scintigraphy with radioiodine-131. A comprehensive list of false-positives with some examples","volume":"20","author":"McDougall","year":"1995","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.soc.2006.05.007_bib59","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/01.mnm.0000169380.92270.73","article-title":"Thyroid stunning in vivo and in vitro","volume":"26","author":"Medvedec","year":"2005","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.soc.2006.05.007_bib60","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/thy.1997.7.277","article-title":"Detection of thyroid remnant\/metastasis without stunning: an ongoing dilemma","volume":"7","author":"Park","year":"1997","journal-title":"Thyroid"},{"key":"10.1016\/j.soc.2006.05.007_bib61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/thy.1994.4.49","article-title":"Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131","volume":"4","author":"Park","year":"1994","journal-title":"Thyroid"},{"key":"10.1016\/j.soc.2006.05.007_bib62","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/00006231-200409000-00004","article-title":"Whole-body scanning with radionuclides of iodine, and the controversy of \u201cthyroid stunning\u201d","volume":"25","author":"Kalinyak","year":"2004","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.soc.2006.05.007_bib63","first-page":"1488","article-title":"Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan","volume":"80","author":"Pineda","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2006.05.007_bib64","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/thy.1997.7.273","article-title":"131I therapy for elevated thyroglobulin levels","volume":"7","author":"Schlumberger","year":"1997","journal-title":"Thyroid"},{"key":"10.1016\/j.soc.2006.05.007_bib65","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1089\/thy.1997.7.669","article-title":"131I treatment of 131I negative whole body scan, and positive thyroglobulin in differentiated thyroid carcinoma: what is being treated?","volume":"7","author":"McDougall","year":"1997","journal-title":"Thyroid"},{"key":"10.1016\/j.soc.2006.05.007_bib66","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1067\/msy.2002.128478","article-title":"Intraoperative ultrasonography improves identification of recurrent thyroid cancer","volume":"132","author":"Karwowski","year":"2002","journal-title":"Surgery"},{"key":"10.1016\/j.soc.2006.05.007_bib67","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00001622-200101000-00008","article-title":"Recombinant human thyrotropin in the management of thyroid cancer","volume":"13","author":"McDougall","year":"2001","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.soc.2006.05.007_bib68","first-page":"3877","article-title":"A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer","volume":"84","author":"Haugen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2006.05.007_bib69","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJM199709253371304","article-title":"Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma","volume":"337","author":"Ladenson","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.soc.2006.05.007_bib70","first-page":"1482","article-title":"A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation","volume":"43","author":"Robbins","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1016\/j.soc.2006.05.007_bib71","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1210\/jcem.86.2.7189","article-title":"Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma","volume":"86","author":"Robbins","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2006.05.007_bib72","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1677\/erc.1.00830","article-title":"rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review","volume":"12","author":"Luster","year":"2005","journal-title":"Endocr Relat Cancer"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105532070600024X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105532070600024X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T11:53:33Z","timestamp":1760961213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105532070600024X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S105532070600024X"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2006.05.007","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Radioactive Iodine in the Treatment of Well-differentiated Thyroid Cancer","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2006.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}